pyrazines has been researched along with Sezary Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, DV; Gibson, HM; Hake, TS; Mishra, A; Porcu, P; Wong, HK | 1 |
Bachelez, H; Courtois, G; Dubertret, L; Jean-Louis, F; Laroche, L; Michel, L; Pellet, C; Sors, A | 1 |
2 other study(ies) available for pyrazines and Sezary Syndrome
Article | Year |
---|---|
Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Cells, Cultured; CTLA-4 Antigen; Female; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Polyubiquitin; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Pyrazines; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes | 2013 |
Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; bcl-2-Associated X Protein; Boronic Acids; Bortezomib; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell, Cutaneous; Middle Aged; NF-kappa B; NF-kappa B p50 Subunit; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Sezary Syndrome; Skin Neoplasms; Transcription Factor RelA | 2006 |